FDA to Require REMS of Opioid-Based Drugs

Citing authority granted to the agency by the FDA Amendments Act of 2007 (FDAAA), FDA sent letters in early February to manufacturers of opioid painkillers, including Ortho McNeil Janssen, Purdue Pharma, Roxanne, King Pharma, Actavis, Xanodyne, Endo, Lavipharm Labs, Mylan […]

Read More